Sunday, October 2, 2022

Insulet revenue growth beats expectations, Talkspace posts net loss during B2B shift and more digital health earnings

Insulin pump-maker Insulet reported net earnings of $27.8 million during the primary quarter this yr, months after it received FDA 510(k) clearance for its Omnipod 5 automated insulin supply system.

The corporate additionally posted $295.4 million in revenue during Q1, in contrast with $252.3 million within the prior yr, beating expectations. Insulet is presently constructing a restricted launch of the Omnipod 5 and plans for a full market launch this yr. 

“The business launch of Omnipod 5 is progressing very effectively, and we’re receiving wonderful buyer suggestions. We additionally lately shared compelling Sort 2 feasibility knowledge that demonstrates how highly effective Omnipod 5 might be for this dramatically underserved inhabitants. Momentum throughout our enterprise continues to develop, and our mission to simplify and enhance the lives of individuals with diabetes stays on the heart of all the pieces we do,” president and CEO Shacey Petrovic mentioned in a press release.

The pump producer additionally introduced Petrovic could be stepping down from her place efficient June 1. Jim Hollingshead, an unbiased member of Insulet’s board, and present president of the sleep and respiratory care enterprise at system maker ResMed, will tackle the position.

Talkspace posted a net loss of $20 million during Q1, in contrast with a $13 million loss within the prior-year interval, because the teletherapy firm shifts its focus to a B2B mannequin.

The corporate famous the elevated loss was pushed by elevated common and administrative bills and greater price of revenue. Talkspace’s gross revenue additionally declined 13%, to $15 million, which it mentioned was as a consequence of its transfer towards B2B, the price of more salaried therapists and their greater compensation.

The teletherapy firm additionally famous its revenue was up 11%, to $30 million, pushed by the B2B phase and offset by a small decline in B2C revenue. 

“We imagine we’ve important alternatives to proceed to develop our B2B enterprise, as we execute our operational agenda, to drive penetration in our lined lives, develop {our relationships} with current health plan companions and launch protection with new payers,” CFO Jennifer Fulk mentioned during an earnings name.

Handheld ultrasound maker Butterfly Network earned $15.6 million in revenue within the first quarter, a more than 25% improve from the prior-year quarter, however reported a net loss of $44.5 million. During Q1 2021, net loss was $0.7 million. 

“For the primary quarter of 2022, adjusted EBITDA was a loss of $40 million in contrast with a loss of $26.5 million for a similar interval in 2021,” president and CEO Dr. Todd Fruchterman mentioned during an earnings name.

“The rise in adjusted EBITDA loss of $13.5 million was pushed by investments in our business and R&D capabilities as we construct out our business operations and merchandise, in addition to investments in future revenue streams.”

Hybrid supplier One Medical beat expectations by incomes $254.1 million in revenue within the first quarter, a big leap in comparison with Q1 final yr, when it introduced in $121.4 million.

The corporate posted a net loss of $90.9 million, and adjusted EBITDA was a loss of $28.9 million. One Medical additionally famous it ended the quarter with 767,000 members, a 28% improve in contrast with 598,000 members final yr.

“In abstract, we’re off to a robust begin for the yr, making impacts for our key stakeholders by our human-centered and technology-powered mannequin. We outperformed our expectations within the quarter, reflecting sturdy execution in opposition to our strategic working plan,” CEO Amir Dan Rubin mentioned during an earnings name. 

“We imagine we’ve by no means been higher positioned to serve more folks in more markets throughout each stage of life with higher health, higher care, higher worth in a greater workforce setting.”

Related Articles


Please enter your comment!
Please enter your name here

Stay Connected

- Advertisement -spot_img

Latest Articles